Knowledge, attitudes, practices and perceptions of clinicians towards conducting clinical trials in an Academic Tertiary Care Center

References

1. ↵
   1. Sackett DL,
   2. Rosenberg WM,
   3. Gray JA,
   4. Haynes RB,
   5. Richardson WS

   (2007) Evidence based medicine: what it is and what it isn't 1996. Clin Orthop Relat Res 455:3–5.
2. ↵
   1. Oxaman AD

   (1995) Checklists for review articles. BMJ 309:648–6513.
3. ↵
   1. Wood A

   (2002) When increased therapeutic benefit comes at increased cost. N Engl J Med 346:1819–1821.
4. ↵
   1. Nelson TD,
   2. Steele RG

   (2007) Predictors of practitioner self-reported use of evidence-3-based practices: Practitioner training, clinical setting, and attitudes toward research. Adm Policy Ment Health 34:319–330.
5. ↵
   1. Joffe S,
   2. Weeks JC

   (2002) Views of American oncologists about the purposes of clinical trials. J Natl Cancer Inst 94:1847–1853.
6. ↵
   1. Grunfeld E,
   2. Zitzelsberger L,
   3. Coristine M,
   4. Aspelund F

   (2002) Barriers and facilitators to enrollment in cancer clinical trials: qualitative study of the perspectives of clinical research associates. Cancer 95:1577–1583.
7. ↵
   1. Prestifilippo J,
   2. Antman K,
   3. Berkman BJ,
   4. Kaufman D,
   5. Lantos J,
   6. Lawrence W Jr.,
   7. et al.

   (1993) The ethical treatment of cancer. What is right for the patient? Cancer 72:2816–2819.
8. ↵
   1. Taylor KM,
   2. Margolese RG,
   3. Soskolne CL

   (1984) Physicians'reasons for not entering eligible patients in a randomized clinical trial of surgery for breast cancer. N Engl J Med 310:1363–1367.
9. ↵
   1. Mansour EG

   (1994) Barriers to clinical trials: Part III: Knowledge and attitudes of health care providers. Cancer 74:2672–2675.
10. ↵
    1. Al-Tannir MA,
    2. El-Bakri N,
    3. Abu-Shaheen AK

    (2016) Knowledge, Attitudes and Perceptions of Saudis towards Participating in Clinical Trials. PLoS One 11:e0143893.
11. ↵
    1. Ellis PM,
    2. Dowsett SM,
    3. Butow PN,
    4. Tattersall MH

    (1999) Attitudes to randomized clinical trials amongst out-patients attending a medical oncology clinic. Health Expect 2:33–43.
12. ↵
    1. Bawazir SA,
    2. Hashan H,
    3. Al Hatareshah A,
    4. Al Ghamdi A,
    5. Al Shahwan K

    (2014) Regulating Clinical Trials in Saudi Arabia. Applied Clinical Research, Clinical Trials & Regulatory Affairs 1:2–9.
13. ↵
    1. Davis DA,
    2. Taylor-Vaisey A

    (1997) Translating guidelines into practice: a systematic review of theoretic concepts, practical experience and research evidence in the adoption of clinical practice guidelines. CMAJ 157:408–416.
14. ↵
    1. Mayer J,
    2. Piterman L

    (1999) The attitudes of Australian GPs to evidence-based medicine: a focus group study. Fam Pract 16:627–632.
15. ↵
    1. Yanagawa H,
    2. Nishiya M,
    3. Miyamoto T,
    4. Shikishima M,
    5. Imura M,
    6. Nakanishi R,
    7. et al.

    (2006) Clinical trials for drug approval: a pilot study of the view of doctors at Tokushima University Hospital. J Med Invest 53:292–296.
16. 1. Sumi E,
    2. Murayama T,
    3. Yokode M

    (2009) A survey of attitudes toward clinical research among physicians at Kyoto University Hospital. BMC Med Educ 9:75.
17. ↵
    1. Ito-Ihara T,
    2. Hong JH,
    3. Kim OJ,
    4. Sumi E,
    5. Kim SY,
    6. Tanaka S,
    7. et al.

    (2013) An international survey of physicians regarding clinical trials: a comparison between Kyoto University Hospital and Seoul National University Hospital. BMC Med Res Methodol 13:130.
18. ↵
    1. World Health Organization

    (2015) WHO world health statistics (Geneva (CH)) Available from: http://www.who.int/whosis/whostat/en/.
19. ↵
    1. Ito-Ihara T,
    2. Hong J,
    3. Kim O,
    4. Sumi E,
    5. Kim S,
    6. Tanaka S,
    7. et al.

    (2013) An international survey of physicians regarding clinical trials: a comparison between Kyoto University Hospital and Seoul National University Hospital. BMC Med Res Methodol 13:130.
20. ↵
    1. Ross S,
    2. Grant A,
    3. Counsell C,
    4. Gillespie W,
    5. Russell I,
    6. Prescott R

    (1999) Barriers to participation in randomised controlled trials: a systematic review. J Clin Epidemiol 52:1143–1156.
21. ↵
    1. Fallowfield L,
    2. Ratcliffe D,
    3. Souhami R

    (1997) Clinicians'attitudes to clinical trials of cancer therapy. Eur J Cancer 33:2221–2229.
22. ↵
    1. Al-Badr AH,
    2. El-Bakri NK,
    3. Abu-Shaheen AK,
    4. Al-Tannir MA

    (2017) Satisfaction and Perception of Researchers towards the Enrollment of Clinical Research Coordinators on Research Conduct and Promptness: A Cross-Sectional Study. Int J Clin Res Trials 2:117.
23. ↵
    1. Somkin CP,
    2. Altschuler A,
    3. Ackerson L,
    4. Geiger AM,
    5. Greene SM,
    6. Mouchawar J,
    7. et al.

    (2005) Organizational barriers to physician participation in cancer clinical trials. Am J Manag Care 11:413–421.
24. ↵
    1. Weinberg AD,
    2. Cooper HP,
    3. Mejia NI,
    4. Spiker CA

    (2004) Attitudes of primary care physicians and specialists about cancer clinical trials: a survey of Texas physicians. Tex Med 100:66–72.
25. ↵
    1. Ashar BH,
    2. Miller RG,
    3. Getz KJ,
    4. Powe NR

    (2004) Prevalence and determinants of physician participation in conducting pharmaceutical-sponsored clinical trials and lectures. J Gen Intern Med 19:1140–1145.
26. ↵
    1. González-Saldivar G,
    2. Rodríguez-Gutiérrez R,
    3. Viramontes-Madrid JL,
    4. Salcido-Montenegro A,
    5. Carlos-Reyna KE,
    6. Treviño-Alvarez AM,
    7. et al.

    (2016) Participants'perception of pharmaceutical clinical research: a cross-sectional controlled study. Patient Prefer Adherence 10:727–34.
27. ↵
    1. Durant RW,
    2. Wenzel JA,
    3. Scarinci IC,
    4. Paterniti DA,
    5. Fouad MN,
    6. Hurd TC,
    7. et al.

    (2014) Perspectives on barriers and facilitators to minority recruitment for clinical trials among cancer center leaders, investigators, research staff, and referring clinicians: enhancing minority participation in clinical trials (EMPaCT). Cancer 120(Suppl 7):1097–1105.
28. ↵
    1. Wang JH,
    2. Sheppard VB,
    3. Liang W,
    4. Ma GX,
    5. Maxwell AE

    (2014) Recruiting Chinese Americans into cancer screening intervention trials: strategies and outcomes. Clin Trials 11:167–177.
29. ↵
    1. Sheldon JM,
    2. Fetting JH,
    3. Siminoff LA

    (1993) Offering the option of randomized clinical trials to cancer patients who overestimate their prognoses with standard therapies. Cancer Invest 11:57–62.
30. 1. Cassileth BR,
    2. Lusk EJ,
    3. Miller DS,
    4. Hurwitz S

    (1982) Attitudes toward clinical trials among patients and the public. JAMA 248:968–970.
31. ↵
    1. Trauth JM,
    2. Musa D,
    3. Siminoff L,
    4. Jewell IK,
    5. Ricci E

    (2000) Public attitudes regarding willingness to participate in medical research studies. J Health Soc Policy 12:23–43.
32. ↵
    1. Robinson G,
    2. Gould M

    (2000) What are the attitudes of general practitioners towards research? Br J Gen Pract 50:390–392.
33. 1. Askew DA,
    2. Clavarino AM,
    3. Glasziou PP,
    4. Del Mar CB

    (2002) General practice research: attitudes and involvement of Queensland general practitioners. Med J Aust 177:74–77.
34. ↵
    1. Rosemann T,
    2. Szecsenyi J

    (2004) General practitioners'attitudes towards research in primary care: qualitative results of a cross sectional study. BMC Fam Pract 5:31.